Company intelligence / Profile preview
Pevion Biotech AG
Bern, Switzerlandlife-sciences-europe.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Pevion’s virosome-based vaccines demonstrated robust immunogenicity and safety profiles in early-stage human trials. The PEV7 therapeutic Candida vaccine showed high mucosal immune response rates in Phase II studies. The malaria vaccine candidate was considered highly promising based on strong immunogenicity data from human trials before being acquired by Mymetics Corporation.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Vaccines (prophylactic and therapeutic)Virosome-based vaccinesProtein antigensImmunostimulants
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Cevec Pharmaceuticals—exclusive license for CAP-T protein expression technology for infectious disease vaccines.Mymetics Corporation—collaboration/outlicensing of malaria program; also licensed HIV virosomal technology from Pevion.
Beyond the preview
Go deeper on Pevion Biotech AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pevion Biotech AG.